The U.S. Department of Health and Human Services (HHS) announces that it is arranging and funding shipments of blood products from the continental United States to Puerto Rico to ensure an adequate supply of safe blood for island residents as the Commonwealth of Puerto Rico experiences active mosquito-borne Zika transmission. The first batch of blood products arrived in Puerto Rico on March 5.
In the absence of special measures to screen for infection or reduce pathogens, the risk of Zika virus transmission through blood products is considered likely based on the most current scientific evidence of how Zika virus and similar viruses (flaviviruses) are spread, and what is currently being reported about transfusion-associated infection occurring outside of the United States. Blood products shipped to Puerto Rico will be collected from areas in the continental United States without active transmission of Zika virus so that blood products used in Puerto Rico can meet all of the same high safety standards as those used elsewhere in the United States.
The shipments are being provided to Puerto Rico through the American Red Cross, the Blood Centers of America, and America’s Blood Centers. Existing blood collection centers in Puerto Rico will then supply that imported blood to transfusion providers.
“Availability of safe blood products for the residents of Puerto Rico is a major priority for HHS,” says Karen B. DeSalvo, MD, MPH, MSc, HHS acting assistant secretary for health. “We are arranging the importation of blood products from areas unaffected by local Zika transmission to ensure the safety of Puerto Rico’s blood supply."
The Food and Drug Administration (FDA) recommends that whole blood and blood components for transfusion be obtained from areas of the United States without active transmission of Zika virus until a blood donor screening test or pathogen reduction technology (where applicable) for Zika virus becomes available. Blood establishments may continue collecting and preparing platelets and plasma if an FDA-approved, pathogen-reduction device is used. Once a blood donor screening test becomes available and is implemented, blood establishments in Puerto Rico will be able to resume routine collection of blood and blood components.
Although an FDA-licensed blood donor screening test and pathogen reduction technology for whole blood and red blood cells are not currently available, facilitating the availability of such a test or technology is a top priority for HHS. A number of HHS components, including the FDA, the Office of the Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), and the Centers for Disease Control and Prevention are working actively with product manufacturers to develop blood donor screening tests and additional pathogen reduction technologies to help protect the nation’s supply of blood and blood components during this outbreak.
The Administration has submitted a $1.9 billion emergency funding request to Congress to respond to the Zika virus both domestically and internationally. Funding requested for ASPR/BARDA, FDA, and the National Institutes of Health (NIH) will accelerate the development of blood donor screening tests, additional pathogen reduction technology, as well as other potential therapies.
Source: HHS
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.